Tag: Prescription Drugs
ACAAI: Epinephrine Auto-Injector Use Low Among Adults With Food Allergy
Furthermore, one-third of adults with food allergy think epinephrine auto-injectors can cause life-threatening effects
Acupuncture Reduces Aromatase Inhibitor-Related Joint Pain
Findings observed in women with early-stage breast cancer who were taking an aromatase inhibitor and had a score of 3 or higher on BPI-WP item
Bepirovirsen Studied for Treatment of Chronic Hepatitis B Infection
Dosage regimens for bepirovirsen explored in phase 2b, randomized, investigator-unblinded trial
Nab-Paclitaxel, Pembrolizumab Combo Active in Advanced Urothelial Cancer
Overall response rate 50 percent among 36 patients with platinum-refractory or cisplatin-ineligible advanced urothelial cancer
Antiepileptic Med Use Increasing in Nursing Home Residents With Dementia
The two most common, valproic acid and gabapentin, being used in clinically distinct ways
ASN: Empagliflozin Cuts Risk for Progression in CKD
Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo
ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease
Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
Association between exposure to antihyperglycemic medications for type 2 diabetes and risk for developing multiple sclerosis differs according to age and sex
AHA: Baxdrostat Studied in Treatment-Resistant Hypertension
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo
